Accessibility Menu
 
enVVeno Medical logo

enVVeno Medical

(NASDAQ) NVNO

Current Price$10.07
Market Cap$6.80M
Since IPO (2018)-100%
5 Year-95%
1 Year-92%
1 Month-4%

enVVeno Medical Financials at a Glance

Market Cap

$6.80M

Revenue (TTM)

$0.00

Net Income (TTM)

$19.47M

EPS (TTM)

$-33.05

P/E Ratio

-0.31

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Price

$10.07

Volume

9,986.581

Open

$10.90

Previous Close

$10.07

Daily Range

$10.04 - $10.90

52-Week Range

$8.67 - $196.70

NVNO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About enVVeno Medical

Industry

Healthcare Equipment and Supplies

Employees

33

CEO

Robert Andrew Berman

Headquarters

Irvine, CA 92618, US

NVNO Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-56%

Return on Capital

-76%

Return on Assets

-66%

Earnings Yield

-3.23%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.80M

Shares Outstanding

655.50K

Volume

9.99K

Avg. Volume

16.12K

Financials (TTM)

Gross Profit

$489.00K

Operating Income

$20.90M

EBITDA

$20.41M

Operating Cash Flow

$15.57M

Capital Expenditure

$5.00K

Free Cash Flow

$15.57M

Cash & ST Invst.

$28.21M

Total Debt

$700.00K

enVVeno Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$117.00K

+4.1%

Gross Margin

0.00%

N/A

Market Cap

$6.80M

N/A

Market Cap/Employee

$183.90K

N/A

Employees

37

N/A

Net Income

$3.74M

+40.0%

EBITDA

$3.90M

+36.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$27.51M

-34.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$310.00K

-55.7%

Short Term Debt

$390.00K

+7.1%

Return on Assets

-65.87%

N/A

Return on Invested Capital

-76.16%

N/A

Free Cash Flow

$3.44M

+32.6%

Operating Cash Flow

$3.44M

+32.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VVOSVivos Therapeutics, Inc.
$0.72+1.47%
CODXCo-Diagnostics, Inc.
$1.64+3.14%
AEMDAethlon Medical, Inc.
$2.38+0.85%
GOVXGeoVax Labs, Inc.
$1.65+16.20%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$113.01+0.04%
NOKNokia
$13.19-0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.14-0.12%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.58+0.05%

Questions About NVNO

What is the current price of enVVeno Medical?

enVVeno Medical is trading at $10.07 per share.

What is the 52-week range for enVVeno Medical?

Over the past 52 weeks, enVVeno Medical has traded between $8.67 and $196.70.

How much debt does enVVeno Medical have?

As of the most recent reporting period, enVVeno Medical reported total debt of $700,000.

How much cash does enVVeno Medical have on hand?

enVVeno Medical reported $3.06M in cash and cash equivalents in its most recent financial results.

What is enVVeno Medical’s dividend yield?

enVVeno Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.